SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

High-tech entrepreneur Moshe Yanai’s debts balloon to $250 million

"A Robin Hood movement to help the smaller developers": How Appcharge is fighting app store monopolies

Full list of Israeli high-tech funding rounds in 2026

Israeli startup bets on psychedelic mushrooms for mental health treatment

Buzz

Most popular

Daily

Weekly

1

The 50 most promising Israeli startups - 2026

2

From Iron Dome to Arrow missiles, unpaid bills accumulate in Israel’s defense sector

3

Five bidders advance in Nice’s $2.5 billion Actimize sale process

4

“Israel will remain a cyber powerhouse for the next decade”

5

SanDisk’s second act: An AI boom, a $160 billion valuation, and a deep Israeli thread

Entera

4 stories about Entera

Drug Developer Entera Bio Down on Nasdaq Following Amgen Deal

12.12.18|Lilach Baumer

The deal, announced Tuesday, could see Entera receive up to $270 million in aggregate payments

תרופות זירת הבריאות

Entera Bio Gives Nasdaq IPO Another Shot

21.05.18|Dror Reich

This is the fourth time since 2014 that the Jerusalem-based biomed company files for an initial public offering on Nasdaq

תל אביב קו רקיע Tel Aviv Skyline

CTech’s Daily Israeli Tech News Roundup

Israeli investment house to open crypto unit. A closer look at the first company funded by Koch’s new venture capital firm. Intuition Robotics expands funding round, nabbing Samsung as an investor.

נאסד"ק וול סטריט

For the Fourth Time, Entera Bio Tries for Nasdaq IPO

08.01.18|Dror Reich

The Jerusalem-based biomed company plans to raise $55 million, with Oppenheimer & Co. as the sole underwriter